Abstract:Cancer treatments are confounded by severe toxic effects toward patients. To address these issues, activatable nanoprobes have been designed for specific imaging and destruction of cancer cells under the stimulation of specific cancer-associated biomarkers. Most activatable nanoprobes were usually activated by some single-factor stimulation, but this restricts therapeutic specificity between diseased and normal tissue; therefore, multifactor activation is highly desired. To this end, we herein develop a novel dual-stimuli responsive theranostic nanoprobe for simultaneously activatable cancer imaging and photothermal therapy under the coactivation of "dual-key" stimulation of "nitric oxide (NO)/acidity", so as to further improve the therapeutic specificity. Specifically, we have integrated a weak electron acceptor (benzo[c][1,2,5]thiadiazole-5,6-diamine) into a donor-π-acceptor-π-donor type chromophore. When the weak acceptor was oxidized by NO in acidic conditions to form a stronger acceptor (5H-[1,2,3]triazolo[4,5-f]-2,1,3-benzothiadiazole), the molecule absorption was significantly increased in the near-infrared region, based on the intramolecular charge transfer (ICT) mechanism. Under the dual-key stimulation of NO/acidity within the tumor associated with inflammation, the nanoprobe can correspondingly output dual signals for ratiometric photoacoustic and photothermal imaging of cancer in vivo and do so with enhanced accuracy and specificity. Our novel nanoprobe exhibited higher photoacoustic signal enhancement under dual-factor activation at 9.8 times that of NO and 132 times that of acidity alone, respectively. Moreover, through such dual activation of NO/acidity, the nanoprobe produces more differentiation of hyperthermia between tumor and normal tissues, to afford satisfactory photothermal therapy with minimal toxic side effects. Thus, our work presents a promising strategy for significantly improving the precision and specificity of cancer imaging and therapy.

Nitric Oxide Activatable Photosensitizer Accompanying Extremely Elevated Two-Photon Absorption for Efficient Fluorescence Imaging and Photodynamic Therapy.

Ultrafast Photoactivated Nitric Oxide Release with a Pyrene Fluorescence Probe

Nitric oxide as an all-rounder for enhanced photodynamic therapy: Hypoxia relief, glutathione depletion and reactive nitrogen species generation

Nitric Oxide-Activated "Dual-Key-One-Lock" Nanoprobe for in Vivo Molecular Imaging and High-Specificity Cancer Therapy

Nitric oxide release triggered by two-photon excited photoluminescence of engineered nanomaterials.

NIR-Triggered On-Demand Nitric Oxide Release for Enhanced Synergistic Phototherapy of Hypoxic Tumor

A light-induced nitric oxide controllable release nano-platform based on diketopyrrolopyrrole derivatives for pH-responsive photodynamic/photothermal synergistic cancer therapy.

In-situ NO release and conversion for highly efficient synergistic gas therapy and phototherapy

NIR Light-Triggered Peroxynitrite Anion Production Via Direct Lanthanide-Triplet Photosensitization for Enhanced Photodynamic Therapy.

Tumor Microenvironment-Activatable Phototheranostic: Leveraging Nitric Oxide and Weak Acidity As Dual Biomarkers for Ratiometric Fluorescence, Photoacoustic Imaging, and Photothermal Therapy

Construction of a Near-Infrared Responsive Upconversion Nanoplatform Against Hypoxic Tumors Via NO-enhanced Photodynamic Therapy

NIR-II-absorbing Conjugated Polymer-Based Theranostic Agent for NIR-II Fluorescence Imaging-Guided Photothermal Therapy Acting Synergistically with Tumor Microenvironment-Responsive Nitric Oxide Therapy

Nitric oxide/PDT combination therapy by the fluorescent self-reporting Co-delivery platforms

Stable Organic Photosensitizer Nanoparticles with Absorption Peak beyond 800 Nanometers and High Reactive Oxygen Species Yield for Multimodality Phototheranostics

Light-triggered nitric oxide release and structure transformation of peptide for enhanced intratumoral retention and sensitized photodynamic therapy

Peroxynitrite (Onoo-) Generation From The Ha-Tpp@Norm Nanoparticles Based On Synergistic Interactions Between Nitric Oxide And Photodynamic Therapies For Elevating Anticancer Efficiency

Near Infrared-Activatable Methylene Blue Polypeptide Codelivery of the NO Prodrug via π-π Stacking for Cascade Reactive Oxygen Species Amplification-Mediated Photodynamic Therapy

Multiple Functions Integrated Inside a Single Molecule for Amplification of Photodynamic Therapy Activity

Semiconducting Polymer Nanotheranostics for NIR-II/Photoacoustic Imaging-Guided Photothermal Initiated Nitric Oxide/photothermal Therapy.

A Nitroreductase-Activatable Near-Infrared Theranostic Photosensitizer for Photodynamic Therapy under Mild Hypoxia.

Supramolecular red-light-photosensitized nitric oxide release with fluorescence self-reporting within biocompatible nanocarriers